Advertisement

Topics

Label concept combines first-opening indication, blinding for clinical trials

16:32 EDT 19 Jun 2017 | Outsourcing-Pharma

Schreiner MediPharm’s new Flexi-Cap for Clinical Trial Supplies provides anti-counterfeit protection with blinding for transparent containers.

Original Article: Label concept combines first-opening indication, blinding for clinical trials

NEXT ARTICLE

More From BioPortfolio on "Label concept combines first-opening indication, blinding for clinical trials"

Advertisement
Quick Search
Advertisement
Advertisement